Testing effectiveness (Phase 2)Ended earlyNCT00389090
What this trial is testing
A Phase II Study of Temozolomide and O6-Benzylguanine (O6-BG) in Patients With Temozolomide-Resistant Anaplastic Glioma
Who this might be right for
GliomaAstrocytomaOligodendroglioma+1 more
Keryx / AOI Pharmaceuticals, Inc. 32